Aster DM Healthcare stock skyrockets 14% after turnaround in Q2FY25
In Thursday’s intraday trading session, the stock of Aster DM Healthcare surged by 13.90% to reach Rs 457.90 per share on the NSE.
In Thursday’s intraday trading session, the stock of Aster DM Healthcare surged by 13.90% to reach Rs 457.90 on the NSE. The impressive performance followed the company’s robust financial results for the second quarter of the fiscal year 2024-25 (Q2FY25).
In the quarter ending in September, the hospital chain rebounded impressively, recording a net profit of Rs 96.84 crore after facing a net loss of Rs 30.79 crore in the corresponding period of the previous fiscal year. The revenue surged by 16% year-on-year to reach Rs 1,086 crore in the second quarter of FY25, as opposed to Rs 934 crore in the same period a year ago.
In Q2FY25, there was a notable enhancement in operational efficiency as the Ebitda margin surged to 21.4%, a significant rise from the 16.8% recorded in the previous year.
Additionally, the healthcare network announced its intention to expand its capacity by introducing more than 1,800 beds by the fiscal year 2027. This expansion will encompass the establishment of the upcoming Aster Women and Child facility in Hyderabad, boasting a total of 300 beds.
Dr. Azad Moopen, the Founder and Chairman of Aster DM Healthcare, expressed satisfaction in the organization’s growth trajectory, aiming to exceed 6,800 beds by FY27. With 9 Aster Hospitals now accredited in the latest Digital Standards Released by NABH, the healthcare provider is poised to cater to the rising need for cutting-edge healthcare services in India.
During the initial six months of FY25, the company saw a positive shift in its payor mix, witnessing a 30 percent increase from insurance business, even as scheme business declined. The prominent Aster Whitefield hospital in Bangalore maintained an occupancy rate of almost 67 percent, generating an average revenue of Rs 70,000 per occupied bed (ARPOB) in H1FY25.
In the first half of the fiscal year 2025, the primary hospital operations achieved an operating EBITDA margin of 22.4%, showing an increase from 19.1% reported in the first half of fiscal year 2024.
The market capitalization of the company stands at Rs 22,233.33 crore, with its shares trading at a price-to-earnings ratio of 59.42.
The company’s stock price rose by 10.72 percent to reach Rs 445.10 per share on the NSE at 10:39 AM. In contrast, the Nifty50 of the NSE dropped 0.03 percent to 24,428.15.
